Industry: Medical Devices & Consumables
Published Date: 2024-09-05
Pages: 111 Pages
Report ld: 3312539
Request Sample
Customized Report
Hemofiltration Replacement/Substitution Fluid Market Size(US$)

CAGR 2024-2030
20.2%
Market Size,2030
USD 6,110
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Hemofiltration replacement/substitution fluid is a special drug for continuous blood purification. It is used to replace water and electrolytes in the body during hemofiltration treatment and replace some kidney functions. The replacement/substitution fluid is different from the basic fluid. The prescription ingredients contain potassium ions and lactate.
The global Hemofiltration Replacement/Substitution Fluid revenue was US$ 1735 million in 2023 and is forecast to a readjusted size of US$ 6110 million by 2030 with a CAGR of 20.2% during the review period (2024-2030).
In United States the Hemofiltration Replacement/Substitution Fluid revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Hemofiltration Replacement/Substitution Fluid market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Hemofiltration Replacement/Substitution Fluid include Baxter, Asahi Kasei, Huaren Pharmaceutical, Shijiazhuang No.4 Pharmaceutical, Chengdu Qingshan Likang Pharmaceutical, China Resources Double Crane Pharmaceutical, etc. The global five biggest players hold a share of % in 2023.
Hemofiltration Replacement/Substitution Fluid market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Hemofiltration Replacement/Substitution Fluid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Hemofiltration Replacement/Substitution Fluid market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Hemofiltration Replacement/Substitution Fluid definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Hemofiltration Replacement/Substitution Fluid companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Hemofiltration Replacement/Substitution Fluid in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemofiltration Replacement/Substitution Fluid sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Hemofiltration Replacement/Substitution Fluid Product Introduction
1.2 Global Hemofiltration Replacement/Substitution Fluid Outlook 2019 VS 2023 VS 2030
1.2.1 Global Hemofiltration Replacement/Substitution Fluid Sales in US$ Million for the Year 2019-2030
1.2.2 Global Hemofiltration Replacement/Substitution Fluid Sales in Volume for the Year 2019-2030
1.3 United States Hemofiltration Replacement/Substitution Fluid Outlook 2019 VS 2023 VS 2030
1.3.1 United States Hemofiltration Replacement/Substitution Fluid Sales in US$ Million for the Year 2019-2030
1.3.2 United States Hemofiltration Replacement/Substitution Fluid Sales in Volume for the Year 2019-2030
1.4 Hemofiltration Replacement/Substitution Fluid Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Hemofiltration Replacement/Substitution Fluid in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Hemofiltration Replacement/Substitution Fluid Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Hemofiltration Replacement/Substitution Fluid Market Dynamics
1.5.1 Hemofiltration Replacement/Substitution Fluid Industry Trends
1.5.2 Hemofiltration Replacement/Substitution Fluid Market Drivers
1.5.3 Hemofiltration Replacement/Substitution Fluid Market Challenges
1.5.4 Hemofiltration Replacement/Substitution Fluid Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Hemofiltration Replacement/Substitution Fluid by Type
2.1 Hemofiltration Replacement/Substitution Fluid Market by Type
2.1.1 Age above 65
2.1.2 Age between 45 and 64
2.1.3 Age below 45
2.2 Global Hemofiltration Replacement/Substitution Fluid Market Size by Type
2.2.1 Global Hemofiltration Replacement/Substitution Fluid Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Hemofiltration Replacement/Substitution Fluid Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Hemofiltration Replacement/Substitution Fluid Market Size by Type
2.3.1 United States Hemofiltration Replacement/Substitution Fluid Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Hemofiltration Replacement/Substitution Fluid Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Hemofiltration Replacement/Substitution Fluid by Application
3.1 Hemofiltration Replacement/Substitution Fluid Market by Application
3.1.1 ICU
3.1.2 Nephrology
3.1.3 Others
3.2 Global Hemofiltration Replacement/Substitution Fluid Market Size by Application
3.2.1 Global Hemofiltration Replacement/Substitution Fluid Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Hemofiltration Replacement/Substitution Fluid Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Hemofiltration Replacement/Substitution Fluid Market Size by Application
3.3.1 United States Hemofiltration Replacement/Substitution Fluid Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Hemofiltration Replacement/Substitution Fluid Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Hemofiltration Replacement/Substitution Fluid Competitor Landscape by Company
4.1 Global Hemofiltration Replacement/Substitution Fluid Market Size by Company
4.1.1 Global Key Manufacturers of Hemofiltration Replacement/Substitution Fluid, Ranked by Revenue (2023)
4.1.2 Global Hemofiltration Replacement/Substitution Fluid Revenue by Manufacturer (2019-2024)
4.1.3 Global Hemofiltration Replacement/Substitution Fluid Sales by Manufacturer (2019-2024)
4.1.4 Global Hemofiltration Replacement/Substitution Fluid Price by Manufacturer (2019-2024)
4.2 Global Hemofiltration Replacement/Substitution Fluid Concentration Ratio (CR)
4.2.1 Hemofiltration Replacement/Substitution Fluid Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hemofiltration Replacement/Substitution Fluid in 2023
4.2.3 Global Hemofiltration Replacement/Substitution Fluid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Hemofiltration Replacement/Substitution Fluid, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Hemofiltration Replacement/Substitution Fluid, Product Offered and Application
4.5 Global Key Manufacturers of Hemofiltration Replacement/Substitution Fluid, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Hemofiltration Replacement/Substitution Fluid Market Size by Company
4.7.1 Key Players of Hemofiltration Replacement/Substitution Fluid in United States, Ranked by Revenue (2023)
4.7.2 United States Hemofiltration Replacement/Substitution Fluid Revenue by Players (2019-2024)
4.7.3 United States Hemofiltration Replacement/Substitution Fluid Sales by Players (2019-2024)
5 Global Hemofiltration Replacement/Substitution Fluid Market Size by Region
5.1 Global Hemofiltration Replacement/Substitution Fluid Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Hemofiltration Replacement/Substitution Fluid Market Size in Volume by Region (2019-2030)
5.2.1 Global Hemofiltration Replacement/Substitution Fluid Sales in Volume by Region: 2019-2024
5.2.2 Global Hemofiltration Replacement/Substitution Fluid Sales in Volume Forecast by Region (2025-2030)
5.3 Global Hemofiltration Replacement/Substitution Fluid Market Size in Value by Region (2019-2030)
5.3.1 Global Hemofiltration Replacement/Substitution Fluid Sales in Value by Region: 2019-2024
5.3.2 Global Hemofiltration Replacement/Substitution Fluid Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Hemofiltration Replacement/Substitution Fluid Market Size YoY Growth 2019-2030
6.2 Americas Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Hemofiltration Replacement/Substitution Fluid Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Hemofiltration Replacement/Substitution Fluid Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Hemofiltration Replacement/Substitution Fluid Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Hemofiltration Replacement/Substitution Fluid Market Size YoY Growth 2019-2030
7.2 EMEA Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Hemofiltration Replacement/Substitution Fluid Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Hemofiltration Replacement/Substitution Fluid Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Hemofiltration Replacement/Substitution Fluid Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Hemofiltration Replacement/Substitution Fluid Market Size YoY Growth 2019-2030
8.2 China Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Hemofiltration Replacement/Substitution Fluid Market Size YoY Growth 2019-2030
9.2 APAC Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Hemofiltration Replacement/Substitution Fluid Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Hemofiltration Replacement/Substitution Fluid Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Hemofiltration Replacement/Substitution Fluid Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Hemofiltration Replacement/Substitution Fluid Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Description and Business Overview
10.1.3 Baxter Hemofiltration Replacement/Substitution Fluid Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Baxter Hemofiltration Replacement/Substitution Fluid Products Offered
10.1.5 Baxter Recent Development
10.2 Asahi Kasei
10.2.1 Asahi Kasei Company Information
10.2.2 Asahi Kasei Description and Business Overview
10.2.3 Asahi Kasei Hemofiltration Replacement/Substitution Fluid Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Asahi Kasei Hemofiltration Replacement/Substitution Fluid Products Offered
10.2.5 Asahi Kasei Recent Development
10.3 Huaren Pharmaceutical
10.3.1 Huaren Pharmaceutical Company Information
10.3.2 Huaren Pharmaceutical Description and Business Overview
10.3.3 Huaren Pharmaceutical Hemofiltration Replacement/Substitution Fluid Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Huaren Pharmaceutical Hemofiltration Replacement/Substitution Fluid Products Offered
10.3.5 Huaren Pharmaceutical Recent Development
10.4 Shijiazhuang No.4 Pharmaceutical
10.4.1 Shijiazhuang No.4 Pharmaceutical Company Information
10.4.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
10.4.3 Shijiazhuang No.4 Pharmaceutical Hemofiltration Replacement/Substitution Fluid Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Shijiazhuang No.4 Pharmaceutical Hemofiltration Replacement/Substitution Fluid Products Offered
10.4.5 Shijiazhuang No.4 Pharmaceutical Recent Development
10.5 Chengdu Qingshan Likang Pharmaceutical
10.5.1 Chengdu Qingshan Likang Pharmaceutical Company Information
10.5.2 Chengdu Qingshan Likang Pharmaceutical Description and Business Overview
10.5.3 Chengdu Qingshan Likang Pharmaceutical Hemofiltration Replacement/Substitution Fluid Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Chengdu Qingshan Likang Pharmaceutical Hemofiltration Replacement/Substitution Fluid Products Offered
10.5.5 Chengdu Qingshan Likang Pharmaceutical Recent Development
10.6 China Resources Double Crane Pharmaceutical
10.6.1 China Resources Double Crane Pharmaceutical Company Information
10.6.2 China Resources Double Crane Pharmaceutical Description and Business Overview
10.6.3 China Resources Double Crane Pharmaceutical Hemofiltration Replacement/Substitution Fluid Sales, Revenue and Gross Margin (2019-2024)
10.6.4 China Resources Double Crane Pharmaceutical Hemofiltration Replacement/Substitution Fluid Products Offered
10.6.5 China Resources Double Crane Pharmaceutical Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Hemofiltration Replacement/Substitution Fluid Industry Chain Analysis
11.2 Hemofiltration Replacement/Substitution Fluid Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Hemofiltration Replacement/Substitution Fluid Production Mode & Process
11.4 Hemofiltration Replacement/Substitution Fluid Sales and Marketing
11.4.1 Hemofiltration Replacement/Substitution Fluid Sales Channels
11.4.2 Hemofiltration Replacement/Substitution Fluid Distributors
11.5 Hemofiltration Replacement/Substitution Fluid Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hemofiltration Replacement/Substitution Fluid market is projected to grow from US$ 2390 million in 2025 to US$ 8539 million by 2032, at a CAGR of 20.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 131
USD 4900.00
(Single User License)
The global Hemofiltration Replacement/Substitution Fluid market size was US$ 2390 million in 2025 and is forecast to reach a readjusted size of US$ 8539 million by 2032 with a CAGR of 20.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
The global market for Hemofiltration Replacement/Substitution Fluid was estimated to be worth US$ 2390 million in 2025 and is projected to reach US$ 8539 million, growing at a CAGR of 20.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 91
USD 3950.00
(Single User License)
The global Hemofiltration Replacement/Substitution Fluid market was valued at US$ 2390 million in 2025 and is anticipated to reach US$ 8539 million by 2032, at a CAGR of 20.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 108
USD 2900.00
(Single User License)
The global Hemofiltration Replacement/Substitution Fluid market is projected to grow from US$ 2022 million in 2024 to US$ 7223 million by 2031, at a CAGR of 20.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 138
USD 4900.00
(Single User License)
The global Hemofiltration Replacement/Substitution Fluid market size was US$ 2022 million in 2024 and is forecast to a readjusted size of US$ 7223 million by 2031 with a CAGR of 20.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
The global market for Hemofiltration Replacement/Substitution Fluid was estimated to be worth US$ 2022 million in 2024 and is forecast to a readjusted size of US$ 7223 million by 2031 with a CAGR of 20.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 103
USD 3950.00
(Single User License)
The global market for Hemofiltration Replacement/Substitution Fluid was valued at US$ 2022 million in the year 2024 and is projected to reach a revised size of US$ 7223 million by 2031, growing at a CAGR of 20.2% during the forecast period.
Published Date: 2025-03-10
Pages: 80
USD 2900.00
(Single User License)
Hemofiltration replacement/substitution fluid is a special drug for continuous blood purification. It is used to replace water and electrolytes in the body during hemofiltration treatment and replace some kidney functions. The replacement/substitution fluid is different from the basic fluid. The prescription ingredients contain potassium ions and lactate.
Published Date: 2024-09-05
Pages: 80
USD 2900.00
(Single User License)
Hemofiltration replacement/substitution fluid is a special drug for continuous blood purification. It is used to replace water and electrolytes in the body during hemofiltration treatment and replace some kidney functions. The replacement/substitution fluid is different from the basic fluid. The prescription ingredients contain potassium ions and lactate.
Published Date: 2024-09-05
Pages: 140
USD 4900.00
(Single User License)
The global Hemofiltration Replacement/Substitution Fluid market is projected to grow from US$ 2390 million in 2025 to US$ 8539 million by 2032, at a CAGR of 20.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 131
The global Hemofiltration Replacement/Substitution Fluid market size was US$ 2390 million in 2025 and is forecast to reach a readjusted size of US$ 8539 million by 2032 with a CAGR of 20.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
The global market for Hemofiltration Replacement/Substitution Fluid was estimated to be worth US$ 2390 million in 2025 and is projected to reach US$ 8539 million, growing at a CAGR of 20.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 91
The global Hemofiltration Replacement/Substitution Fluid market was valued at US$ 2390 million in 2025 and is anticipated to reach US$ 8539 million by 2032, at a CAGR of 20.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 108
The global Hemofiltration Replacement/Substitution Fluid market is projected to grow from US$ 2022 million in 2024 to US$ 7223 million by 2031, at a CAGR of 20.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 138
The global Hemofiltration Replacement/Substitution Fluid market size was US$ 2022 million in 2024 and is forecast to a readjusted size of US$ 7223 million by 2031 with a CAGR of 20.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
The global market for Hemofiltration Replacement/Substitution Fluid was estimated to be worth US$ 2022 million in 2024 and is forecast to a readjusted size of US$ 7223 million by 2031 with a CAGR of 20.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 103
The global market for Hemofiltration Replacement/Substitution Fluid was valued at US$ 2022 million in the year 2024 and is projected to reach a revised size of US$ 7223 million by 2031, growing at a CAGR of 20.2% during the forecast period.
Published: 2025-03-10
Pages: 80
Hemofiltration replacement/substitution fluid is a special drug for continuous blood purification. It is used to replace water and electrolytes in the body during hemofiltration treatment and replace some kidney functions. The replacement/substitution fluid is different from the basic fluid. The prescription ingredients contain potassium ions and lactate.
Published: 2024-09-05
Pages: 80
Hemofiltration replacement/substitution fluid is a special drug for continuous blood purification. It is used to replace water and electrolytes in the body during hemofiltration treatment and replace some kidney functions. The replacement/substitution fluid is different from the basic fluid. The prescription ingredients contain potassium ions and lactate.
Published: 2024-09-05
Pages: 140
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now